What the FDA Isn’t Telling You About Apricot Seeds

What the FDA Isn’t Telling You About Apricot Seeds: A Deep Dive into the Suppression Debate Over Natural Cancer Therapies

When it comes to cancer, the dominant narrative tends to center on pharmaceutical-based treatment: chemotherapy, radiation, and surgery. But beneath that familiar story lies another: one that points to natural substances like amygdalin—found in Apricot Seeds, often called Vitamin B17—as potential tools in the fight against cancer, and to a long history of regulatory battles over access to those therapies.

The Origins of Apricot Seeds and Amygdalin

In the early to mid-20th century, researchers explored the compound amygdalin (and its semi-synthetic derivative, Laetrile) as a potential natural anti-cancer agent.

Supporters reported anecdotal cases of tumor shrinkage, improved quality of life, and accessible alternatives beyond conventional

Continue reading